Palisade Bio (PALI) Other Working Capital Changes (2010 - 2026)
Palisade Bio (PALI) reported Other Working Capital Changes of -$22000.0 for Q1 2026, up 31.25% year-over-year from -$16761.9 in Q1 2025, and down 117.32% quarter-over-quarter from $127000.0 in Q3 2025.
Palisade Bio (PALI) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Other Working Capital Changes data on file, last reported at -$22000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$22000.0, up 31.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $71000.0 (up 1875.0% YoY), and the FY2025 annual result was $61000.0, changed N/A from the prior year.
- Other Working Capital Changes eased to -$22000.0 in Q1 2026 per PALI's latest filing, from $127000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $360000.0 in Q4 2022 and troughed at -$472000.0 in Q2 2023.
- A 5-year average of -$28866.7 and a median of -$32000.0 in 2025 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes sank 863.27% in 2023, then jumped 452.53% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $360000.0 in 2022, then sank by 130.28% to -$109000.0 in 2023, then surged by 420.18% to $349000.0 in 2024, then plunged by 63.61% to $127000.0 in 2025, then slumped by 117.32% to -$22000.0 in 2026.
- Business Quant data shows PALI's Other Working Capital Changes at -$22000.0 in Q1 2026, $127000.0 in Q3 2025, and -$34000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Sep 30, 2024 | 349,000.00 |
| Sep 30, 2024 | 349,000.00 |
| Jun 30, 2024 | -321,000.00 |
| Jun 30, 2024 | -321,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -109,000.00 |
| Dec 31, 2023 | -109,000.00 |
| Sep 30, 2023 | -99,000.00 |
| Sep 30, 2023 | -99,000.00 |
| Jun 30, 2023 | -472,000.00 |
| Jun 30, 2023 | -472,000.00 |